Insulet Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Insulet Stock Summary

Insulet competes with DexCom, STERIS Plc, Koninklijke Philips, Zimmer Biomet, and Biogen. Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. Insulet Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2300 people.

Insulet Key Financial Ratios

Insulet Key Balance Sheet Accounts

Insulet Key Income Statement Accounts

Insulet Key Cash Accounts

Insulet Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Insulet's current stock value. Our valuation model uses many indicators to compare Insulet value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Insulet competition to find correlations between indicators driving Insulet's intrinsic value. More Info.Insulet is regarded third in return on equity category among its peers. It also is regarded third in return on asset category among its peers reporting about  0.44  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Insulet is roughly  2.25 . At present, Insulet's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Insulet by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Insulet Systematic Risk

Today, most investors in Insulet Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Insulet's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Insulet growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Insulet help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Insulet. We use our internally-developed statistical techniques to arrive at the intrinsic value of Insulet based on widely used predictive technical indicators. In general, we focus on analyzing Insulet Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Insulet's daily price indicators and compare them against related drivers.

When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.